L. Merkel

发表

AMP 579, a Novel Adenosine Agonist for the Treatment of Acute Myocardial Infarction

K. Clark, B. Boutouyrie, P. Zannikos, 2006 .

Pharmacological characterization of AMP 579, a novel adenosine A1/A2 receptor agonist and cardioprotective

A. Spada, K. Clark, M. Jarvis, 1998 .

Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2‐ but not to an A1‐agonist in the dog

B. Cox, M. Perrone, L. Merkel, 1994, British journal of pharmacology.

Cardiovascular and antilipolytic effects of the adenosine agonist GR79236.

D. Colussi, B. Cox, M. Perrone, 1995, Pharmacology.

Cardiovascular and metabolic effects of adenosine A1-receptor agonists in streptozotocin-treated rats.

K. Clark, D. Colussi, B. Cox, 1997, Journal of cardiovascular pharmacology.

Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.

B. Cox, R. Lappe, M. Perrone, 1992, The Journal of pharmacology and experimental therapeutics.

Preconditioning of human smooth muscle cells via cyclopentenone prostaglandins protects against toxic effects of oxidized low-density lipoprotein.

K. Clark, M. Kenney, C. Rojas, 2000, Biochemical and biophysical research communications.

Modulation of vascular reactivity by vasoactive peptides in aortic rings from hypercholesterolemic rabbits.

G. Bilder, L. Merkel, 1992, European journal of pharmacology.

Differential effects of the adenosine A1 receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranes

M. Jarvis, B. Cox, G. Martin, 1999, Brain Research.

In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.

R. Lappe, M. Perrone, L. Merkel, 1992, European journal of pharmacology.

Dissociation between myosin phosphorylation and shortening velocity in canine trachea.

W. Gerthoffer, T. Torphy, L. Merkel, 1990, The American journal of physiology.

Zaprinast: A cGMP-Selective Phosphodiesterase Inhibitor

L. Merkel, 1993 .

Enzyme inhibition during the conversion of squalene to cholesterol

S. Needle, G. Bilder, M. Perrone, 1995, Steroids.

Prolonged Relaxation of Detergent-Skinned Smooth Muscle Involves Decreased Endogenous Phosphatase Activity

J. Di Salvo, J. C. Ruegg, L. Merkel, 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Cyclic GMP-dependent protein kinase relaxes skinned fibers from guinea pig taemia coli but not from chicken gizzard

F. Hofmann, G. Pfitzer, L. Merkel, 1986, Pflügers Archiv.

In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202.

D. Colussi, B. Cox, M. Perrone, 1993, The Journal of pharmacology and experimental therapeutics.

Potential of adenosine receptor agonists for the prevention and treatment of coronary artery disease and acute myocardial infarction

K. Clark, L. Merkel, 2000 .

Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A.

C. Dunwiddie, A. Spada, P. Persons, 1999, Circulation.

Induction of heat shock protein 70 by herbimycin A and cyclopentenone prostaglandins in smooth muscle cells

A. Zilberstein, A. Spada, A. Ardati, 2000, Cell stress & chaperones.

Interaction of smooth muscle tropomyosin and smooth muscle myosin. Effect on the properties of myosin.

D. Hartshorne, M. Ikebe, L. Merkel, 1989, Biochemistry.

Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation.

L. Merkel, L. Rivera, Mark H. Perrone, 1991, The Journal of pharmacology and experimental therapeutics.